Mycophenolate (Oral)
Embryofetal Toxicity, Malignancies and Serious InfectionsUse during pregnancy is associated with increased risks of first trimester pregnancy loss and congenital malformations. Avoid if safer treatment options are available. Females of reproductive potential must be counseled regarding pregnancy prevention and planning.Increased risk of development of lymphoma and other malignancies, particularly of the skin.Increased susceptibility to infections, including opportunistic infections and severe infections with fatal outcomes .
Oral route(Tablet, Enteric Coated)Embryo-Fetal Toxicity, Malignancies, and Serious InfectionsUse during pregnancy is associated with increased risks of pregnancy loss and congenital malformations. Avoid if safer treatment options are available. Females of reproductive potential must be counseled regarding pregnancy prevention and planning.Only physicians experienced in immunosuppressive therapy and management of organ transplant patients should prescribe mycophenolate sodium. Patients receiving mycophenolate sodium should be managed in facilities equipped and staffed with adequate laboratory and supportive medical resources. The physician responsible for maintenance therapy should have complete information requisite for the follow-up of the patient.Increased risk of development of lymphoma and other malignancies, particularly of the skin, due to immunosuppression.Increased susceptibility to bacterial, viral, fungal, and protozoal infections, including opportunistic infections .
Commonly used brand name(s)
In the U.S.
- Cellcept
- Myfortic
Available Dosage Forms:
- Capsule
- Powder for Suspension
- Tablet
- Tablet, Enteric Coated
Therapeutic Class: Immune Suppressant
Uses for mycophenolate
Mycophenolate belongs to a group of medicines known as immunosuppressive agents. It is used with other medicines (eg, cyclosporine, steroid medicine) to lower the body's natural immunity in patients who receive kidney transplants.
When a patient receives an organ transplant, the body's white blood cells will try to get rid of (reject) the transplanted organ. Mycophenolate prevents the white blood cells from rejecting the transplanted organ.
Mycophenolate is available only with your doctor's prescription.
Before using mycophenolate
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For mycophenolate, the following should be considered:
Allergies
Tell your doctor if you have ever had any unusual or allergic reaction to mycophenolate or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Pediatric
Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of mycophenolate in children 5 years of age and older who had a kidney transplant at least 6 months before. However, safety and efficacy have not been established in children younger than 5 years of age.
Geriatric
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of mycophenolate in the elderly. How
